Haleon (LON:HLN) Reaches New 12-Month High at $396.80

Haleon plc (LON:HLN) shares hit a new 52-week high during trading on Monday . The company traded as high as GBX 396.80 ($5.24) and last traded at GBX 396 ($5.23), with a volume of 16512637 shares traded. The stock had previously closed at GBX 393.10 ($5.19).

Analysts Set New Price Targets

Separately, Berenberg Bank upped their price target on Haleon from GBX 410 ($5.42) to GBX 447 ($5.90) and gave the stock a “buy” rating in a research report on Monday, August 5th.

Haleon Price Performance

The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93. The firm has a 50-day moving average of GBX 365.07 and a 200-day moving average of GBX 340.05. The stock has a market cap of £36.34 billion, a PE ratio of 3,297.50, a PEG ratio of 1.47 and a beta of 0.19.

Haleon Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, September 19th. Investors of record on Thursday, August 15th will be given a dividend of GBX 2 ($0.03) per share. This represents a dividend yield of 0.57%. The ex-dividend date of this dividend is Thursday, August 15th. Haleon’s dividend payout ratio is currently 5,000.00%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.